Immune Tolerance Ensured By Dendritic Cells One of the most important tasks of the immune system is to identify what is foreign and what is self. If this distinction fails, then the body's own structures will be attacked, the result of which could be an autoimmune disease such as diabetes mellitus type 1 or multiple sclerosis.
Source: www.medicalnewstoday.comPeripheral Artery Disease Approximately 1.5 million people live in 17,000 nursing homes within the United States. Ninety percent are 65 years or older and 24 percent are 85 years or older. It is estimated that by 2030, more than 8 million seniors will reside in nursing homes or long-term care facilities. Reports show that with the advance in [...]
Source: feedproxy.google.comAntibiotic-Resistant Organisms: Hospital Infection Control Strategies Hand-washing, a clean environment, appropriate infection barriers and early identification of patients at high risk of colonization with a transmissible microorganism remain the essential measures to prevent and control infection. A review of hospital infection control strategies in CMAJ http://www.cmaj.ca/press/pg627.pdf looks at the most effective methods and the supporting evidence.
Source: www.medicalnewstoday.comOrexo: Orexo's Edluar (Sublinox) Receives FDA Approval For The Treatment Of Insomnia Orexo (STO:ORX) announces that the US Food and Drug Administration (
FDA) has approved Edluar (formerly Sublinox) 5 mg and 10 mg sublingual tablets for the short-term treatment of insomnia characterized by difficulties with sleep initiation.
Source: www.medicalnewstoday.comCause For Severe Pediatric Epilepsy Disorder Identified Researchers at the University of California, San Diego School of Medicine have discovered that convulsive seizures in a form of severe epilepsy are generated, not on the brain's surface as expected, but from within the memory-forming hippocampus.
Source: www.medicalnewstoday.comCinryze Infusion Reverses Plasma Activation In Hereditary Angioedema WASHINGTON DC - New data show that replacement therapy with Cinryze (C1 inhibitor-nf) infusion reverses all abnormalities of the plasma bradykinin-forming pathway and fibrinolysis that are responsible for the swelling attacks in patients with hereditary angioedema (HAE).
Source: www.medicalnewstoday.comDivided Opinion On Pill Splitting Patients, looking to save money on their prescriptions are increasingly putting pills under the knife…or, to be safe, a pill splitter. They are cutting pills at the suggestion of friends, their doctor and, in some cases, their insurance company. This latest way to circumvent the pharmaceutical industry leaves many patients and providers asking what the [...]
Source: feedproxy.google.comHow to avoid spring allergies Though the first day of spring is still a week away, those with seasonal allergies know that the harbingers of spring are already, quite literally, in the air. If the sudden warm snap, which has triggered the release of a slew of plant pollens, has your eyes watering, nose running, and throat clogged, then you might [...]
Source: feedproxy.google.comTracking Down And Attacking Cancer Cells Using Nanoscopic Probes A researcher has developed probes that can help pinpoint the location of tumors and might one day be able to directly attack cancer cells. Joseph Irudayaraj, a Purdue University associate professor of agricultural and biological engineering, developed the nanoscale, multifunctional probes, which have antibodies on board, to
search out and attach to cancer cells.
Source: www.medicalnewstoday.comDNA 'Patch' For Canine Form Of Muscular Dystrophy Lays The Foundation For Human Testing Using a novel genetic technology that covers up genetic errors, researchers funded in part by the National Institutes of Health have developed a successful treatment for dogs with the canine version of Duchenne muscular dystrophy, a paralyzing, and ultimately fatal, muscle disease. The technology, known as "exon skipping" uses tailor-made snippets of DNA-like molecules as molecular "patches.
Source: www.medicalnewstoday.com
# posted by Network @ 3:58 PM
